Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Brain Res ; 856(1-2): 281-90, 2000 Feb 21.
Article in English | MEDLINE | ID: mdl-10677637

ABSTRACT

We evaluated the delivery of 14C-cytosine arabinoside (AraC) to rat brain by: 1) intravenous (IV) bolus, by 2) intrathecal (IT) and 3) intraventricular (IVT) infusion, and by 4) convection-enhanced delivery (CED) into the caudate nucleus. Plasma and brain AraC metabolites were measured with HPLC, and distribution and concentration of 14C-AraC in brain sections were measured by quantitative autoradiography. After IV administration, the alpha and beta plasma half-lives were 1.9 and 46.5 min, respectively. The blood-to-brain transfer constant of AraC was 2.5+/-1.4 microliter g(-1) min(-1), compatible with high water solubility. After IT and IVT administration, tissue levels were high at the brain and ventricular surfaces, but declined exponentially into brain. After CED, maximum brain levels were up to 10,000 times higher than the IV group, and the distribution pattern was one of high 14C-AraC concentration in the convective component, with exponentially declining concentrations outside this region. The rate loss constant from brain was 0.002+/-0.0004 min(-1), suggesting that AraC was accumulating in brain cells. AraC was metabolized into uracil arabinoside within the brain. 14C-AraC was infused into 1 dog and distributed widely in the ipsilateral hemisphere. These studies suggest that delivery of AraC to brain parenchyma by the IV, IT or IVT routes will be subtherapeutic. Delivery by CED can achieve, and maintain, therapeutic levels of AraC in the brain, and should be further evaluated as a potential method of drug delivery.


Subject(s)
Brain/metabolism , Caudate Nucleus/metabolism , Cytarabine/administration & dosage , Cytarabine/pharmacokinetics , Animals , Carbon Radioisotopes , Cytarabine/blood , Dogs , Half-Life , Infusions, Parenteral , Injections, Intravenous , Injections, Intraventricular , Injections, Spinal , Rats , Rats, Sprague-Dawley , Tissue Distribution
2.
J Neurotrauma ; 12(5): 897-901, 1995 Oct.
Article in English | MEDLINE | ID: mdl-8594217

ABSTRACT

Posttraumatic cerebral arterial spasm (vasospasm) has been demonstrated in the past by angiography, and recently by transcranial Doppler ultrasonography. Posttraumatic vasospasm is a delayed complication that involves the large basal intracranial arteries (e.g., internal carotid, middle cerebral, basilar) and occurs in 25-40% of head trauma patient. The time course of posttraumatic vasospasm resembles that of vasospasm associated with aneurysmal subarachnoid hemorrhage with onset occurring 2 or more days after injury. A study of the relationship of admission CT scan findings to the incidence of vasospasm suggests that intradural bleeding, which extends into the CSF (subarachnoid, intraventricular, and subdural hemorrhage), plays a role in the pathogenesis of posttraumatic arterial spasm. The preliminary results of a large prospective study of head trauma patients suggest that vasospasm may be an important determinant of outcome from severe head injury.


Subject(s)
Brain Injuries/complications , Ischemic Attack, Transient/etiology , Brain Injuries/epidemiology , Brain Injuries/physiopathology , Humans , Ischemic Attack, Transient/epidemiology , Ischemic Attack, Transient/physiopathology , Prospective Studies , Risk , Spasm/etiology , Spasm/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...